These findings indicate that, as a transcriptional activator of CCR4 and a regulator of Treg invasion, FOXP3 overexpression is related to the good prognosis of breast cancer and plays an important role in the tumor microenvironment of breast cancer (102–104). Here, FOXP3 is linked to breast cancer.